About Us
Crucial Data Solutions (CDS) is the leading developer of validated, fully customizable eClinical software.
Our unified platform, TrialKit, is purpose-built for clinical research teams to design, deploy, and manage studies in days—no programming required.
With a cloud-based, open architecture, TrialKit gives research teams the flexibility to manage all types of studies across all phases of development. Our eClinical platform brings together essential study management capabilities with advanced AI technology to accelerate study design, development, validation, and analysis. Whether you have one or two studies in your pipeline or are managing a larger volume of studies, our platform license agreement (PLA) model gives you the freedom to build and manage your studies your way. Available via web and mobile app, TrialKit supports patient-centric remote, hybrid/decentralized, and site-based clinical trials.
Verily (a subsidiary of Alphabet), Google, ICON plc, and Catalyst Clinical Research are just a few of our recent happy customers. We work with medical device, diagnostics, and biotech sponsors, CROs, academic institutions, and patient advocacy groups.

Our History and Our Reason
Crucial Data Solutions was founded in 2010 by a group of clinical technology experts to help drug and medical device companies get their products to market faster. By launching TrialKit, they created an alternative to high-cost, high-burden data collection and study management solutions on the market.
TrialKit was designed to address unmet needs for medtech, pharma and biotech sponsors and CROs looking for a more seamless, cost-effective solution.
To this day, Crucial Data Solutions remains focused on its founding mission: helping research teams reclaim control of their studies through advanced, affordable clinical technology. That commitment continues to drive our investment in emerging technologies, including artificial intelligence. From AI-assisted study building and validation to study simulation and data analysis, we’re continually expanding TrialKit’s capabilities to meet the evolving needs of clinical research.
How We Work
Technology is what we do best.
We focus exclusively on developing technology for clinical research. This specialization allows us to continuously advance TrialKit with new capabilities, emerging technologies, and innovations that address the changing needs of research teams, while maintaining the quality and support our customers expect.
You come first.
Our customer-first approach drives everything we do, from product updates to how we structure our team.
We’re accessible.
With over 60,000 users around the globe, we average less than 10 support requests per day, which are responded to in an average of less than 10 minutes. We’re here when you need us.
We’re privately held and self-funded.
This allows us to steadily improve and expand our products while keeping our pricing model affordable — almost unheard of in this industry.
Our Team
Paul Grady
Chief Executive Officer/President
Kevin Grady
Chief Financial Officer
Melchizedek Mauleon
Chief Technology Officer
Leigh J. Mack, MD, PhD
Chief Medical Officer
Cody Wilke
Director of Quality Assurance
Paul Fadden
Director of Client Services
Carley Nolan
Director of Marketing
Eric Kaye
Senior Technical Lead
Cody England
Controller
Kelsi Sigl
Project Manager










